Sarepta Therapeutics, Inc.
Status: Publicly traded
Direct answer
Sarepta Therapeutics, Inc. is publicly traded on NASDAQ under the ticker SRPT.
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to the discovery and advancement of genetic treatment modalities, including RNA-targeted therapeutics and gene therapies, specifically for rare diseases. The company currently offers two approved treatments: EXONDYS 51, prescribed for Duchenne muscular dystrophy (DMD) patients with confirmed dystrophin gene mutations amenable to...
Can you invest in Sarepta Therapeutics, Inc.?
Yes. Sarepta Therapeutics, Inc. is publicly traded on NASDAQ under the ticker SRPT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Sarepta Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.